TGFB1 and cancer: TGF-β signaling plays a significant role in mediating drug resistance in various cancers via actions on the expression of drug efflux transporters, alteration of cell cycle checkpoints, and modulation of apoptosis pathways, all which can reduce the efficacy of anticancer drugs [31–35].